Altre lingue Iris Acquisition Corp

Azioni

IRAA

US89601Y1010

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:01 25/04/2024			Variaz. 5gg	Var. 1 gen.
10,38 ^USD	-2,35%		-2,26%	+0,48%

17/04	Iris Acquisition Corp riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
12/01	Iris Acquisition Corp riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023	17/04
Iris Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	12/01
Iris Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K	02/01
Iris Acquisition Corp announced that it has received $1.5 million in funding	04/10/23
Iris Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23
Iris Acquisition Corp Appoints Nicholas Fernandez as Director	02/06/23
Iris Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	02/05/23
Iris Acquisition Corp Announces Resignation of Borade as A Member of the Board	02/05/23
IRIS ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	18/04/23
Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2022	18/04/23
FTX revival effort draws possible bid from VC firm Tribe Capital - Bloomberg News	18/04/23
Iris Acquisition Corp Auditor Raises 'Going Concern' Doubt	18/04/23
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	31/03/23
IRIS ACQUISITION CORP : Change in Directors or Principal Officers (form 8-K)	19/01/23
Iris Acquisition Corp Appoints Borade Shashibhushan to Serve as A Director	19/01/23
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	28/12/22
IRIS ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23/12/22
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	20/12/22
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp	06/12/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Iris Acquisition Corp

Azioni

IRAA

US89601Y1010

Altre lingue

Filtri